Detection of Lung Tumor Movement in Real-time Tumor-tracking Radiotherapy
Overview
Affiliations
Purpose: External radiotherapy for lung tumors requires reducing the uncertainty due to setup error and organ motion. We investigated the three-dimensional movement of lung tumors through an inserted internal marker using a real-time tumor-tracking system and evaluated the efficacy of this system at reducing the internal margin.
Methods And Materials: Four patients with lung cancer were analyzed. A 2.0-mm gold marker was inserted into the tumor. The real-time tumor-tracking system calculates and stores three-dimensional coordinates of the marker 30 times/s. The system can trigger the linear accelerator to irradiate the tumor only when the marker is located within the predetermined "permitted dislocation." The value was set at +/-1 to +/-3 mm according to the patient's characteristics. We analyzed 10,413-14,893 data sets for each of the 4 patients. The range of marker movement during normal breathing (beam-off period) was compared with that during gated irradiation (beam-on period) by Student's t test.
Results: The range of marker movement during the beam-off period was 5.5-10.0 mm in the lateral direction (x), 6.8-15.9 mm in the craniocaudal direction (y) and 8.1-14.6 mm in the ventrodorsal direction (z). The range during the beam-on period was reduced to within 5.3 mm in all directions in all 4 patients. A significant difference was found between the mean of the range during the beam-off period and the mean of the range during the beam-on period in the x (p = 0.007), y (p = 0.025), and z (p = 0.002) coordinates, respectively.
Conclusion: The real-time tumor-tracking radiotherapy system was useful to analyze the movement of an internal marker. Treatment with megavoltage X-rays was properly given when the tumor marker moved into the "permitted dislocation" zone from the planned position.
Shirato H Proc Jpn Acad Ser B Phys Biol Sci. 2023; 99(9):389-426.
PMID: 37821390 PMC: 10749389. DOI: 10.2183/pjab.99.024.
Yasue K, Fuse H, Oyama S, Hanada K, Shinoda K, Ikoma H J Radiat Res. 2021; 63(1):137-147.
PMID: 34718704 PMC: 8776700. DOI: 10.1093/jrr/rrab098.
Bednarz B, Jupitz S, Lee W, Mills D, Chan H, Fiorillo T Phys Med. 2021; 88:104-110.
PMID: 34218199 PMC: 8403156. DOI: 10.1016/j.ejmp.2021.06.017.
de Bruin K, Dahele M, Mostafavi H, Slotman B, Verbakel W Adv Radiat Oncol. 2021; 6(4):100705.
PMID: 34113742 PMC: 8170355. DOI: 10.1016/j.adro.2021.100705.
Gated Radiotherapy Development and its Expansion.
Keikhai Farzaneh M, Momennezhad M, Naseri S J Biomed Phys Eng. 2021; 11(2):239-256.
PMID: 33937130 PMC: 8064130. DOI: 10.31661/jbpe.v0i0.948.